Categories
Connect with us on LinkedIn
The impact of an AI-enabled consent process
Exploring how early engagement with trial participants through an AI enabled chatbot can enhance both comprehension and satisfaction.
Spring updates & a highlight on ePRO in Oncology
Listen in as Derk gives an update on what is happening at Castor this March, as well as...
Kicking-off 2024: A year of optimism & opportunity
Listen in for Derk’s take on the JPM conference, and what to expect from a first quarter filled...
The AI Hype and Reality: Key Highlights from CNS Summit 2023
At this year's CNS Summit, Castor achieved a remarkable feat by winning the AI Demo Awards. Watch more...
What to expect at the CNS Summit Live AI Demo
As the world works towards a future of AI-assisted solutions, we believe that everyone who is involved in...
Understand Barriers to eConsent Adoption from Site and Sponsor Perspectives
Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.
Harnessing the power of Patient-centric Technologies
Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.
AI & Air Hockey – What to expect at DIA?
Listen to our CEO & Founder, Derk Arts, as he reflects on lessons learned from the BIO panel...
Unlocking the potential of GPT-generated eConsent for IRB approval
As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these...
Considerations for the use of RWE in FDA Assessments
As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these...
Improving Your Consent Process with Generative AI
As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these...
Real-World Evidence: The Importance of Standardization & Democratization
As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these...
2023 Making a Positive Impact
As we kick-off 2023 with a refreshed mindset, we take inventory of what is important and focus on...
Digital Trials: Reinventing new definitions for clinical research
There are ongoing debates about whether or not our industry should call all decentralized ones digital trials; however,...
Continuing the pursuit of technology in the conduct of informed consent
Many researchers are still hesitant to adopt digital informed consent due to a misconception that digital forms are...
Debunking Similar Misconceptions of Remote Workplace to Decentralized Clinical Trials
Listen to our CEO & Founder Derk Arts share his thoughts about why remote-first is the only way...
Engaging Trial Sites with Technology
In this first release of Download with Derk, our CEO & Founder discussed best practices for effective collaboration...
